Polyglutamine-expanded ataxin-3 causes cerebellar dysfunction of SCA3 transgenic mice by inducing transcriptional dysregulation

Polyglutamine-expanded ataxin-3 causes cerebellar dysfunction of SCA3 transgenic mice by inducing transcriptional dysregulation

In the present study, we prepared a SCA3 animal model by generating transgenic mice expressing polyglutamine-expanded ataxin-3-Q79. Ataxin-3-Q79 was expressed in brain areas implicated in SCA3 neurodegeneration, including cerebellum, pontine nucleus and substantia nigra. Ataxin-3-Q79 transgenic mice...

Full description

Bibliographic Details
Main Authors:	An-Hsun Chou, Tu-Hsueh Yeh, Pin Ouyang, Ying-Ling Chen, Si-Ying Chen, Hung-Li Wang
Format:	Article
Language:	English
Published:	Elsevier 2008-07-01
Series:	Neurobiology of Disease
Subjects:	Spinocerebellar ataxia type 3 Ataxin-3 Polyglutamine-expanded ataxin-3 SCA3 transgenic mice Cerebellum Microarray analysis
Online Access:	http://www.sciencedirect.com/science/article/pii/S0969996108000673

Similar Items

HDAC inhibitor sodium butyrate reverses transcriptional downregulation and ameliorates ataxic symptoms in a transgenic mouse model of SCA3
by: An-Hsun Chou, et al.
Published: (2011-02-01)

Polyglutamine-expanded ataxin-3 activates mitochondrial apoptotic pathway by upregulating Bax and downregulating Bcl-xL
by: An-Hsun Chou, et al.
Published: (2006-02-01)

Polyglutamine-induced neurodegeneration in SCA3 is not mitigated by non-expanded ataxin-3: Conclusions from double-transgenic mouse models
by: Jeannette Hübener, et al.
Published: (2010-04-01)

Ataxin-3 protein modification as a treatment strategy for spinocerebellar ataxia type 3: Removal of the CAG containing exon
by: Melvin M. Evers, et al.
Published: (2013-10-01)

Tissue-Specific Vulnerability to Apoptosis in Machado-Joseph Disease
by: Ana F. Ferreira, et al.
Published: (2023-05-01)

Implications of specific lysine residues within ataxin-3 for the molecular pathogenesis of Machado-Joseph disease
by: Priscila Pereira Sena, et al.
Published: (2023-05-01)

Broad Influence of Mutant Ataxin-3 on the Proteome of the Adult Brain, Young Neurons, and Axons Reveals Central Molecular Processes and Biomarkers in SCA3/MJD Using Knock-In Mouse Model
by: Kalina Wiatr, et al.
Published: (2021-06-01)

Twenty-five years since the identification of the first SCA gene: history, clinical features and perspectives for SCA1
by: Carlos Roberto Martins Junior, et al.

A new humanized ataxin-3 knock-in mouse model combines the genetic features, pathogenesis of neurons and glia and late disease onset of SCA3/MJD
by: Pawel M. Switonski, et al.
Published: (2015-01-01)

Impaired interactions of ataxin-3 with protein complexes reveals their specific structure and functions in SCA3 Ki150 model
by: Piotr Piasecki, et al.
Published: (2023-03-01)

Identification of the ataxin-1 interaction network and its impact on spinocerebellar ataxia type 1
by: Jiu-Ming Chen, et al.
Published: (2022-07-01)

Neurodegenerative phosphoprotein signaling landscape in models of SCA3
by: Anna S. Sowa, et al.
Published: (2021-03-01)

Ataxin-3, The Spinocerebellar Ataxia Type 3 Neurodegenerative Disorder Protein, Affects Mast Cell Functions
by: Anna S. Sowa, et al.
Published: (2022-04-01)

Allosteric regulation of deubiquitylase activity through ubiquitination
by: Serena eFaggiano, et al.
Published: (2015-02-01)

Machado-Joseph Disease: from first descriptions to new perspectives
by: Bettencourt Conceição, et al.
Published: (2011-06-01)

The deubiquitinase ataxin-3 requires Rad23 and DnaJ-1 for its neuroprotective role in Drosophila melanogaster
by: Wei-Ling Tsou, et al.
Published: (2015-10-01)

Plasma PolyQ-ATXN3 Levels Associate With Cerebellar Degeneration and Behavioral Abnormalities in a New AAV-Based SCA3 Mouse Model
by: Karen Jansen-West, et al.
Published: (2022-03-01)

Expanded ataxin-7 cause toxicity by inducing ROS production from NADPH oxidase complexes in a stable inducible Spinocerebellar ataxia type 7 (SCA7) model
by: Ajayi Abiodun, et al.
Published: (2012-07-01)

Autophagy in Spinocerebellar Ataxia Type 3: From Pathogenesis to Therapeutics
by: Rodrigo Paulino, et al.
Published: (2023-04-01)

Sleep Alterations in a Mouse Model of Spinocerebellar Ataxia Type 3
by: Maria-Efstratia Tsimpanouli, et al.
Published: (2022-10-01)

Inhibition of colony-stimulating factor 1 receptor early in disease ameliorates motor deficits in SCA1 mice
by: Wenhui Qu, et al.
Published: (2017-05-01)

Combined overexpression of ATXN1L and mutant ATXN1 knockdown by AAV rescue motor phenotypes and gene signatures in SCA1 mice
by: Ellie M. Carrell, et al.
Published: (2022-06-01)

Ataxin-3 and its E3 partners: Implications for Machado-Joseph disease
by: Thomas M Durcan, et al.
Published: (2013-05-01)

Mitochondrial Morphology, Function and Homeostasis Are Impaired by Expression of an N-terminal Calpain Cleavage Fragment of Ataxin-3
by: Tina Harmuth, et al.
Published: (2018-10-01)

Ectoine alters subcellular localization of inclusions and reduces apoptotic cell death induced by the truncated Machado–Joseph disease gene product with an expanded polyglutamine stretch
by: Kentaro Furusho, et al.
Published: (2005-10-01)

Spinocerebellar Ataxia Type 2: Clinicogenetic Aspects, Mechanistic Insights, and Management Approaches
by: Luis C. Velázquez-Pérez, et al.
Published: (2017-09-01)

The Josephin domain (JD) containing proteins are predicted to bind to the same interactors: Implications for spinocerebellar ataxia type 3 (SCA3) studies using Drosophila melanogaster mutants
by: Rita Sousa e Silva, et al.
Published: (2023-03-01)

Rescue of ATXN3 neuronal toxicity in Caenorhabditis elegans by chemical modification of endoplasmic reticulum stress
by: Yasmin Fardghassemi, et al.
Published: (2017-12-01)

Evaluation of Antisense Oligonucleotides Targeting ATXN3 in SCA3 Mouse Models
by: Lauren R. Moore, et al.
Published: (2017-06-01)

Mitochondrial Dysfunction in Spinocerebellar Ataxia Type 3 Is Linked to VDAC1 Deubiquitination
by: Tina Harmuth, et al.
Published: (2022-05-01)

Transcriptional repression and cell death induced by nuclear aggregates of non-polyglutamine protein
by: Lianwu Fu, et al.
Published: (2005-12-01)

Human cytomegalovirus UL97 kinase prevents the deposition of mutant protein aggregates in cellular models of Huntington's disease and Ataxia
by: Cristy Tower, et al.
Published: (2011-01-01)

Gene Deregulation and Underlying Mechanisms in Spinocerebellar Ataxias With Polyglutamine Expansion
by: Anna Niewiadomska-Cimicka, et al.
Published: (2020-06-01)

A peptide inhibitor that rescues polyglutamine-induced synaptic defects and cell death through suppressing RNA and protein toxicities
by: Shaohong Isaac Peng, et al.
Published: (2022-09-01)

Altered retinal structure and function in Spinocerebellar ataxia type 3
by: Vasileios Toulis, et al.
Published: (2022-08-01)

Nystagmus may be the first neurological sign in early stages of spinocerebellar ataxia type 3
by: Maria Thereza Drumond Gama, et al.
Published: (2021-01-01)

Ataxin-3 Links NOD2 and TLR2 Mediated Innate Immune Sensing and Metabolism in Myeloid Cells
by: Thomas P. Chapman, et al.
Published: (2019-07-01)

Cerebellar neuronal dysfunction accompanies early motor symptoms in spinocerebellar ataxia type 3
by: Kristin Mayoral-Palarz, et al.
Published: (2022-08-01)

ATTCT and ATTCC repeat expansions in the ATXN10 gene affect disease penetrance of spinocerebellar ataxia type 10
by: C. Alejandra Morato Torres, et al.
Published: (2022-10-01)

A native interactor scaffolds and stabilizes toxic ATAXIN-1 oligomers in SCA1
by: Cristian A Lasagna-Reeves, et al.
Published: (2015-05-01)